Works matching IS 17762596 AND DT 2020 AND VI 15 AND IP 2
Results: 10
Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Impact of Prior Ramucirumab Use on Treatment Outcomes of Checkpoint Inhibitors in Advanced Gastric Cancer Patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer.
- Published in:
- 2020
- By:
- Publication type:
- research
Targeting Apoptosis in Acute Myeloid Leukemia: Current Status and Future Directions of BCL-2 Inhibition with Venetoclax and Beyond.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Oral Azacitidine and Cedazuridine Approximate Parenteral Azacitidine Efficacy in Murine Model.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for Advanced EGFR-Positive Lung Adenocarcinoma Patients: Updated Data and Exploratory In Vitro Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial Carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-Label, Single-Arm, Single-Center Prospective Pilot Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice.
- Published in:
- 2020
- By:
- Publication type:
- journal article